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Bruno Schneider Herrera: Searching for New Periodontal Pathogens:  Insights from an Enhanced 
RNA-Oligonucleotide Quantification Technique (ROQT)  
(Under the direction of Flavia Teles, Steven Offenbacher, and Julie Marchesan). 
Aims: Fifty percent of the oral microbiome remains unrecognized or uncultured. In order to 
study this segment of the microbiota, we previously developed the RNA-Oligonucleotide 
Quantification Technique (ROQT). The aim of this study was to optimize the ROQT technique 
regarding its sensitivity, specificity and cost-effectiveness. Material and Methods: Total nucleic 
acids (TNA) were extracted from bacterial suspensions and subgingival biofilm samples using 
manual and an automated protocol. RNA, DNA and Locked Nucleic Acid (LNA) digoxigenin-
labeled oligonucleotide probes targeting 21 cultured/uncultured taxa were synthesized. Tests were 
performed using 10ng TNA, 106 bacterial cells, and RNA and DNA standards for quantification. 
Probe specificity was determined by targeting 96 oral bacterial species; sensitivity was assessed 
using serial dilutions of reference bacterial strains. The tested conditions were assessed in a small 
pilot study with subgingival biofilm samples. Significance of differences between test conditions 
and subject groups was determined using the Mann–Whitney U-test. Results: LNA-
oligunucleotides probes yielded stronger signals without cross-reactions, when compared with 
DNA and RNA oligonucleotides probes. The automated method at 63C consistently yields 
stronger signals in comparison to the manual protocol. Samples from patients with periodontitis 
showed higher levels of subgingival bacteria based on the universal probe signals than samples 
from periodontally healthy subjects. Overall, the most commonly detected 
	
iv	
uncultivated/unrecognized species in the samples from severe sites were probe Treponema sp 
ot254, TM7 ot356, Fretibacterium sp ot360, Y73 Selenomonas sp ot134, 54, and Desulfobulbus 
sp. ot041. In the cultivated segment of the microbiota, the most abundant taxa were Tannerella 
forsythia ot613, L66 Oribacterium sp ot78, K76 Bacterioidetes sp ot274, Fretibacterium 
fastidiosum ot363 and Porphyromonas gingivalis ot619. Conclusion: The use of automated TNA 
extraction, LNA probes and RNA standards enhances the sensitivity, specificity, throughput, and 
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The oral cavity harbors a complex microbiome, with close to 700 taxa capable of colonizing 
the oral cavity1. Most of the current knowledge regarding the microbial aspects of periodontal 
health and disease, as well as changes in the microbiome that result from periodontal treatment are 
based on the cultivated segment of the microbiome, largely guided by the seminal work of 
Socransky et al (1998)2 on the subgingival microbial complexes. However, there is a substantial 
portion of the oral microbiome that has not yet been fully characterized or has remained 
uncultured1.  
Although the role of the unrecognized/uncultivated organisms in periodontal health and 
disease is currently unknown, there is no reason to expect that this segment of the microbiota 
harbors fewer pathogens than its cultivated counterpart. In fact, it is possible that a red complex 
“equivalent” might exist among unrecognized and uncultivated taxa. In that scenario, it becomes 
crucial to study them in detail, so that their pathogenic properties can be unveiled. However, the 
first challenge in that process is to determine which organisms are relevant to health maintenance 
and for disease initiation. There are currently 94 unrecognized taxa and 208 uncultured phylotypes 
described in the Human Oral Microbiome Database (www.homd.org3) it is unlikely that they are 
all equally important in the pathogenesis of periodontitis. 
In order to select which of those taxa merit further study, one needs to determine whether the 
taxa presence levels are likely to have a role in the dysbiotic environment that precedes disease 
initiation. With that in mind, in 2011, Teles et al.4  developed the RNA-Oligonucleotide 
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Quantification Technique, a cost-effective approach to enumerate uncultivated/unrecognized taxa 
in individual samples of subgingival biofilm samples4,5. ROQT can overcome limitations of other 
techniques that require sample dilution, sample pooling or PCR amplification6–10, all of which can 
add bias to the microbial results. In addition, it provides quantification, a key piece of information 
in the study of microbial shifts in periodontal health and disease, as the differences between 
periodontal health and disease and before and after therapy are quantitative, rather than 
qualitative2,11. The utility of ROQT has been demonstrated in several papers that have helped 
identify new candidate periodontal pathogens12,13. 
But first, we will give an overview about the biology of the biofilm, its ecological relationship, 









REVIEW OF THE LITERATURE 
BIOLOGY OF THE BIOFILM 
Among the advances in microbiology that have taken place over the past 50 years, the study 





Many different biofilms exist in nature; some are useful (to the human), and others are 
associated with potentially harmful effects. Dental plaque is a naturally-occurring biofilm that has 
the potential to cause disease. Dental plaques have many properties in common with biofilms 
found in other locations. However, they have certain characteristics that are important in terms of 
the development and control of the periodontal diseases15. 
The features, structure and the basic components of biofilms: There are four characteristics of 
biofilm: autopoiesis (the ability to self-organize), homeostasis (to resist environmental 
perturbations	that	results	in	new	homeostatic	states), synergy (must be more effective in association 
than in isolation) and communality (should respond to environmental changes as a unit rather than 
as single individuals)15. 
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In a biofilm, residing bacteria are protected from environmental threats; trapping of nutrients 
and metabolic cooperation between resident cells of the same species and/or different species is 
allowed by the biofilm structure. It also exhibits organized internal compartmentalization, which 
helps the bacterial species in each compartment with different growth requirements. These 
bacterial cells in a biofilm community may acquire new traits by communicating and exchanging 
genetic materials15,16. 
It is composed of matrix material consisting of proteins, polysaccharides, nucleic acids, and 
salt, which makes up 85% by volume, while 15% is made up of cells17. 
An article published by Socransky and Haffajee in 200218 compare the development of a 
biofilm with  the development of a city.  
Briefly, cities (like biofilms) develop by an initial “attachment” of humans followed by 
multiplication of the existing inhabitants. They typically spread different directions, forming 
columnar habitation sites. Cities and biofilms offer their inhabitants many benefits, like shared 
resources, interrelated activities, protection both from other potential colonizers and from sudden 
harmful changes in the environment. Individuals in the community can facilitate joint activities 
and live in a far more stable environment than individuals living in isolation. In cities and biofilms, 
there are roads, water or sewage pipes. Communication is essential to allow inhabitants to interact 
optimally. The long-term survival of the human species as well as a species in a biofilm becomes 
more likely if that species colonizes multiple sites. Thus, detachment of cells from biofilms and 
establishment in new sites is as important and can establish new colonies18. 
The steps of biofilm development on dental surfaces: The nature of initial bacteria–substrate 
interaction is determined by physicochemical properties such as surface energy and charge density. 
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The bacteria adhere to a substrate by bacterial surface structures such as fimbriae, pili, flagella, 
and extracellular polymeric substances (glycocalyx). Bridges are formed between the bacteria and 
the conditioning film by these bacterial structures19. 
Molecular-specific interactions between bacterial surface structures and substrate become 
active. These bridges are a combination of electrostatic attraction, covalent and hydrogen bonding, 
dipole interaction, and hydrophobic interaction. Porphyromonas gingivalis, Streptococcus mitis, 
Streptococcus salivarius, Prevotella intermedia, Prevotella nigrescens, Streptococcus mutans, and 
Actinomyces naeslundii are some of the oral bacteria possessing surface structures15. 
With the help of polysaccharide adhesin or ligand formation, which binds to receptors on the 
substrate, specific bacterial adhesion with a substrate is produced.  Microcolony is formed by the 
monolayer of microbes, which attracts secondary colonizers, and gives rise to the final structure 
of biofilm. This metabolically active community of microorganisms is a mature biofilm where 
individuals share duties and benefits.  Two types of microbial interactions occur at the cellular 
level during the formation of biofilm: coadhesion and coaggregation15. 
Some of the reasons why biofilms are such difficult therapeutic targets: Costerton et al. 
(1999)20 stated that a wide range of human infections are due to biofilms. These include dental 
caries, periodontal disease, otitis media, musculoskeletal infections, necrotizing fasciitis, biliary 
tract infection, osteomyelitis, bacterial prostatitis, native valve endocarditis, meloidosis and cystic 
fibrosis pneumonia21. Characteristic of these infections is the persistence and chronicity of the 
infections as well as the difficulty in their eradication20. 
Generally, multidrug resistance, more than any other property of biofilms, provides a clear 
demonstration that population behavior is not the sum of the contributions of single cells. Biofilms 
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are unique multicellular constructions of bacteria from one or several species, in which horizontal 
genetic transfer may occur easily, thus facilitating crossbreeding of resistance genes22 and for	
collateral	protection. 
In the case of dental biofilms, they are easily accessible and thus allow direct removal and 
application of antimicrobial agents. However, they are microbiologically very complex22. This 
complexity helps the periodontist in one way and presents problems in another. The complexity 
helps to assure the therapist that treatment will usually lead to the return of a relatively similar, 
diverse microbial plaque; hopefully with pathogenic species reduced or eliminated. If treatment 
virtually eliminated all or most species, the potential for colonization by even more harmful 
organisms would be very high. On the other hand, the complexity can present difficulties for the 
therapist. On the other hand, treatments reduce diversity, antibody response controls what can 
emerge and certain niches are reduced with treatment. The first is knowing which of several 
potential pathogens in an individual is causing that individual's disease. The second is that the 
network provided by the community structure may help to “rescue” a suppressed species by 
providing the essential factors needed for rapid recolonization23. 
BIOFILM AND ITS ECOLOGICAL RELATIONSHIP 
The environmental diversity of the oral cavity promotes the establishment of distinct microbial 
communities, such as supragingival and subgingival plaque, and tongue coating. The properties of 
the environment determine which microorganisms can occupy a site, while the metabolic activities 
of those microbial communities subsequently modify the properties of the environment24. 
Nutrition: Oral microflora uses substrates either derived from the diet of the host or produced 
by other bacteria. Host substrates are derived from the constituents of saliva and crevicular fluid 
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(both of which contains low amounts of glucose and proteins). Oral microorganisms are efficient 
at producing enzymes like proteases, lipases and glycoside hydrolases to degrade and use polymers 
produced by the host25. On example of this interaction is Veilonella that can utilize lactic acid 
produced by Streptococci as it cannot ferment carbohydrates on its own. Similarly, certain strains 
of Bacteroides melaninogenicus require Vitamin K produced by other bacteria for growth. Hence 
there is a symbiotic nutritional relationship between the commensal oral bacteria present in the 
mouth. 
Signaling: Bacteria communicate between themselves by releasing special molecules. This is 
particularly vital for colony growth and biofilm formation as it sets up the basis of coaggregation 
between different oral microflora. One example is Streptococcus gordonii which produces H2O2 
to kill other oral bacteria, but it does not have catalases to breakdown H2O2. However, another 
bacterial species called Actinnomyces naeslundi produce catalase, which breaks down some of the 
H2O2 that S. gordonii cannot hydrolyze26. This suggests possible signaling interactions between 
these two organisms that allow both to flourish together but prevents growth competition with 
other bacteria. 
Adhesion: Biofilms can be formed in a variety of oral cavity surfaces including saliva-coated 
enamel and dental root surfaces. Primary colonizers do the initial attachment, which results in the 
formation of microbial monolayers. The adherence is initially a long ranged non-specific reversible 
interaction, but then followed by an irreversible short ranged adhesion-receptor interaction27. With 
time and arrival of other late colonizers, the microbial monolayer gives rise to a multilayered bio-
film as the late colonizers bind to the primary colonizers by co-adhesion. The late colonizers 
synthesize protein adhesins, which cannot bind to the salivary pellicle but is efficient in binding to 
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the receptors the primary colonizers. This mechanism where microflora bind to each other to form 
biofilm is called coaggregation28. This is important because the bacteria present in the biofilm 
community work together to not only outcompete pathogenic bacteria for resources (like space 
and nutrition) but also have mutualistic nutritional inter-relationships among themselves. 
Ecological plaque hypothesis: Historically, the first plaque hypothesis was the “Specific 
Plaque Hypothesis” in 197629. It proposes that only a few species of the total microflora are 
actively involved in disease. Secondly, the “Non-Specific Plaque Hypothesis”, updated in 198630, 
was the idea that the overall activity of the total microflora could lead to disease was enriched by 
taking into account difference in virulence among bacteria. Then, a hypothesis was considered that 
combines key concepts of the earlier two hypotheses: the “Ecological Plaque Hypothesis” by 
Marsh (1994)31, which proposes that disease is the result of an imbalance in the microflora by 
ecological stress resulting in an enrichment of certain disease-related micro-organisms32. 
The key feature is that the enhancement of certain types of bacteria in the oral cavity is directly 
related to changes in the environment. 
Periodontal disease: Health-associated species with an insignificant role in gingival 
inflammation could significantly contribute to a change in growth conditions favoring pro-
inflammatory bacteria. For example, facultative anaerobic Rothia spp. has recently been associated 
with oral health and reduces the oxygen levels in the direct environment32. This in turn allows 
proliferation of strict anaerobes, which include proteolytic Gram-negative bacteria that contribute 
to triggering the inflammation. Accumulation of commensal microbiota results in an increase in 
GCF that in turn changes the environment because GCF contains high levels of proteins that are a 
novel source of nutrients. Furthermore, GCF contains iron that triggers keystone pathogen 
	
9	
mechanisms in P. gingivalis. Increased bacterial accumulation triggers more inflammation, which 
leads to a vicious circle where the host is producing more GCF, more protein and more iron32. 
Environmental changes in periodontitis: The crosstalk between the host and the bacterial 
biofilm is diverse and bidirectional. The host response and environmental changes induce stress in 
the biofilm bacteria. For example, the change in the local pH towards an alkaline environment 
appears to play an important role in the shift towards periodontopathogenic biofilm composition. 
The biofilm mass is increased in alkaline conditions and, in particular, the intermediate coloniser 
F. nucleatum displays increased adhesion and coaggregation with other bacteria33. Another 
example is the inflammatory environment, the increase of oxidative stress and the inflammatory 
cytokine IL-1β result in decreased metabolism in periodontal biofilm but still increase various 
virulence factors as well as biofilm formation. In summary, the environmental changes generated 
in inflammation favor biofilm formation and appear to drive the bacteria into the shelter provided 
by the	extracellular polymeric substance and the lower metabolic activity. 
MICROBIOLOGY OF PERIODONTAL DISEASES 
Historical perspective: The subgingival microbiota is complex and has been recognized as 
such since the first microscopic examination by Van Leeuwenhoek in 168332. With the 
development of the light and electron microscopy, cultural techniques and more recently 
immunologic or DNA probe techniques, researchers were able to understand with more detail what 
specific microorganisms are present in the biofilm.  
In 1975, Listgarten et al.34 showed that early supragingival plaque has a columnar arrangement 
of morphologically distinct bacterial species from the tooth surface to the outer surface of the 
plaque. In addition, in 197435 and 197636, Listgarten demonstrated that subgingival plaque was 
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frequently characterized by a zone of gram negative and/or motile species located adjacent to the 
epithelial lining of the pocket while gram positive rods and cocci appeared to be forming a tightly 
adherent band of organisms on the enamel or root surface. 
Gmur et al. (1989)37, with probe assessments of plaque, have demonstrated that certain species 
frequently occur together in subgingival plaque. For example, P. gingivalis is almost always 
observed with B. forsythus in the dental biofilm. In addition, Simonson et al. 1992 observed P.  
gingivalis is frequently found with T. denticola and Ali et al. (1994)38 found the same pattern with 
F. nucleatun and P intermedia in subgingival plaque samples from deep pockets in a group of 
adult periodontitis subjects. 
Kigure et al. (1995)39 using immunohistochemical techniques provided graphic demonstration 
of the relationship between T. denticola and P. gingivalis in biopsies of subgingival plaque, 
epithelial and connective tissues from different pocket depths in human periodontitis subjects. 
Simonson et al. (1992)40 and Haffajee et al. (1997)41 demonstrated a reduction in the species of 
this complex after scaling and root planing. 
Technological developments permitted the evaluation of large numbers of bacterial species in 
large numbers of plaque samples from a wide range of subjects. 
In 1988, Socransky et al.42 observed that some microorganisms are found together in groups 
that can lead to the development of periodontal diseases. All these previous findings contributed 
to the development of the study of the microbial complexes in subgingival plaque by Socransky’s 
group. 
Using the checkerboard DNA-DNA hybridization technique (developed by Socransky et al. 
in 199443), Socransky et al. (1998)2 analyzed subgingival plaque from 185 subjects. Using the 
	
11	
entire database, as well as subsets of data, they presented for the first time a multiple cluster and 
community ordination analyses. In this study, they proposed a diagrammatic representation 
(colored coded) of the relationships of species within microbial complexes and between the 
microbial complexes.  
They observed that red complex consists of the tightly related group with B. forsythus (now 
T. forsythia) P. gingivalis and T. denticola. The red complex showed the strongest relationship 
with the clinical parameters considered most meaningful in periodontal diagnosis. For example, 
the individual species in the complex as well as the complex itself related very strongly with pocket 
depth and bleeding on probing. The orange complex is composed by F. nucleatum, P. intermedia. 
P nigrescens and P. micros. This complex is also strongly related with the development of the 
periodontal diseases and serves as a bridge to the red complex species2.  
The yellow complex consisted of S. sanguis. S. oralis, S. mitls. S. gordonii and S. intermedius. 
The green complex comprises three Capnocytophaga species, C. concisus and E. eorrodens; and 
the purple complex consisted of V. parvula and A. odontotylicus. A. actinotnycetemcomitans, S. 
taxia and A. naeslundii genospecies were outliers with little relation to each other and the 5 major 
complexes2.  
In gingivitis, the initial microbial colonization of the plaque biofilm seems to involve members 
of the yellow, green and purple complexes. They are also sometimes related to the healthy 
periodontal status. The two species in the purple complex were strongly related to each other and 
to a lesser extent to members of the orange, green and yellow complexes. The reasons for these 
relationships among complexes is unclear but Grenier (1996)44 speculated that it might be that 
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antagonistic relationships may exist or that environments selective for one group may be less 
hospitable to a second group of organisms. 
New putative pathogens in periodontal disease: The current paradigm of the microbial 
etiology of periodontitis implicates numerically minor gram-negative anaerobic components of the 
plaque biofilm, such as P. gingivalis, T. forsythensis, and T. denticola, as the primary etiologic 
agents. Although several lines of evidence are available to support an etiologic role for these 
species, the epidemiologic data linking these species to disease was obtained with closed-ended 
approaches that would not allow the detection and enumeration of previously unidentified and 
uncultivated species45. 
In 2001, using cloning and Sanger sequencing, Paster et al.46 suggested a possible role of 
cultivable as well as not-yet-cultivable/unrecognized microbial species in the etiology of 
periodontitis, confirming the idea that the diversity of the oral microbiota was more complex than 
previously known. Subsequently, a number of other studies using several molecular approaches 
were published in the periodontal literature47. 
Kumar et al. (2005)45, using 16S PCR amplification with universal 16S primers of dental 
plaque samples, followed by cloning and sequencing demonstrated that several genera, many of 
them uncultivated, were associated with periodontitis, the most numerous of which were gram 
positive, including Peptostreptococcus and Filifactor. The genera Megasphaera and 
Desulfobulbus, and the levels of several species or phylotypes of Campylobacter, Selenomonas, 
Deferribacteres, Dialister, Catonella, Tannerella, Streptococcus, Atopobium, Eubacterium, and 
Treponema were elevated in disease. Griffen et al. (2012)48, not only confirmed these findings, but 
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also included one Gram-positive bacterium, Filifactor alocis, which is potentially important in 
disease. 
Oliveira et al. (2016)13 demonstrated the association of 5 uncultivated/unrecognized 
phylotypes Bacteroidales sp. HOT 274, TM7 sp. HOT 356, Desulfobulbus sp. HOT 041, 
Fretibacterium sp. HOT 360, and Fretibacterium sp. HOT 362 with generalized chronic and 
aggressive periodontitis. 
This large numbers of additional species will be targets for future research and elucidate major 
shifts in phylogenetic community composition, these studies could provide the basis for further 
understanding host–microbe interactions in health and disease48. 
Bacterial analysis in periodontal diseases: Since certain subgingival bacterial species play 
pivotal roles in the initiation and progression of periodontal diseases, bacterial quantification has 
been explored as an indicator of disease activity. In addition, several approaches have been 
proposed for using assessments of subgingival microbiota to guide periodontal therapy. However, 
because of technical limitations, these studies have focused solely on cultivable species for which 
polymerase chain reaction (PCR) primers, DNA probes, antibodies, or biochemical assays will be 
available. Teles et al (2011)4 have developed RNA-oligonucleotide quantification technique 
(ROQT) to detect and quantify up to 30 uncultivable/unrecognized and cultivable taxa in 30 
biofilm samples.  One of the many challenges of investigating the pathogenesis of periodontal 
diseases is that approximately 50% of the subgingival microbiota are uncultivable/unrecognized. 
These “unknown” species may offer important, yet unexplored diagnostic properties.   The 
focus of microbial tests on periodontal pathogens has also been largely biased, showing little 
attention to beneficial or “bystander” species that might present surprising contributions to 
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multivariate diagnostic models.  Until recently, few tools will be available to study 
uncultivable/unrecognized species at a site level. 
Since the Teles et al. (2011)4 publication, it became important to improve the technique, to 










Thus, the purpose of this study was to optimize the ROQT technique regarding its sensitivity, 
specificity and cost-effectiveness in terms of laboratory and personal use. Specifically, we propose 
to analyze the efficacy and sensitivity of the locked nucleic acid (LNA)-modified oligonucleotides 
probes and to shift to the use of RNA complementary sequences for the preparation of the standards 
for quantification. In addition, we analyzed the automated extraction of total nucleic acids from 
clinical samples by using the KingFisher technology (Thermo Fisher Scientific, Waltham, MA). 
Furthermore, the plan is to use ROQT to quantify selected cultivated and uncultivated bacterial 
species in subgingival plaque samples. We anticipate that both cultivated and uncultivated species 












Two types of samples were used to test the efficacy, sensitivity, specificity and throughput of 
the modifications proposed to ROQT protocol: total nucleic acids extracted from a) bacterial cells 
obtained from reference strains and b) subgingival biofilm samples. 
Bacterial cells: as a result of the unavailability of cells from uncultivated/unrecognized 
bacterial species, cells from reference bacterial species were used as test species for validation 
purposes in this study (Table 1). The strains were grown in specific media described in Teles et 
al., 20114. Bacterial cells were harvested from agar plates, placed into 200 µl of RNAse-free TE 
buffer (10 mM Tris–HCl, 0.1 mM EDTA, pH 7.6) and kept at −80°C until extraction of TNA. 
Subgingival plaque samples: Subgingival plaque samples were collected from healthy 
subjects and from patients with severe and moderate periodontitis. Samples were taken separately 
from mesio-buccal and disto buccal sites using sterile Gracey curettes (HuFriedy, Chicago, IL) 
and placed in individual 0.5 mL Matrix tubes containing 200 µl RNAse-free TE buffer. Samples 
were kept at −80°C until TNA extraction. The detailed methods are presented below. 
Extraction of Total Nucleic Acids 
Extraction of TNA from all samples was performed using the MasterPure™ Complete DNA 
and RNA Purification Kit (Epicentre, Madison, WI) was recommended by the manufacturer and 
the MagMAX™ Pathogen RNA/DNA Kit-4462359 (Applied Biosystems, Foster City, CA) with 
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Kingfisher Flex instrument for automated TNA extraction. For the automated protocol, the biofilm 
samples were added to microcentrifuge tubes containing 450 µL of Lysis/Binding Solution and 
vortex mixed for 3 minutes. Then, the mixture was centrifuged at 16,000 × g for 2 minutes to 
clarify the lysate. The sample plate was prepared as follows:  20 µL of prepared Bead Mix was 
added to one MME-96 Deep Well Plate containing 600 µL of prepared sample (clarified lysate) 
and 350 µL of 100% isopropanol. The plate was immediately processed in the Kingfisher Flex 
using the program MagMAX™ provided by the manufacturer.  Ninety microliters of purified TNA 
were obtained in the elution plate and were kept at −80°C until analysis, when the entire sample 
was laid onto a positively charged nylon membrane. 
Ninety microliters of 2% glutaraldehyde and 910 µl 6 × SSC (where 1 × SSC = 150 mM NaCl, 
15 mM sodium citrate, pH 7.0) were added to each sample. The final solutions were deposited in 
individual lanes of a Minislot (Immunetics, Boston, MA), concentrated onto a nylon membrane 
(Roche-Sigma-Aldrich, St. Louis, MO) by absorption with 15 sheets of 3mm chromatography 
paper (GE/Whatman TM) and fixed onto the membrane by cross-linking using ultraviolet light (UV 
Crosslinker, Fisher Scientific) and dried at room temperature. The Minislot device permitted the 
deposition of 30 different plaque samples in individual ‘lanes’ on a single 15 × 15-cm nylon 
membrane. In this study, we used 23 samples, 1 quality control sample (QCS) and 6 standards with 
different concentrations of complementary sequences for quantification of each test species, 
presented in detail below. 
Probe Preparation 
Digoxigenin labeled Locked Nucleic Acid (LNA)TM customized oligonucleotides probes were 
synthesized by Exiqon (Woburn, MA). Probes targeted the 16S ribosomal DNA (rDNA) gene of 
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4 cultivated species and 19 uncultivated bacterial taxa (Table 2). Sequences were 17-22 
nucleotides in length and had minimal secondary structure. The probe panel also included one 
universal (eubacterial) probe that targeted a conserved region of the bacterial 16S rDNA gene. All 
probes used in this study were based on sequences previously employed in the Human Oral 
Microbial Identification Microarray (HOMIM). The full list of probe sequences has been published 
elsewhere49.  
Hybridization using Oligonucleotide Probes 
Before hybridization, the membranes were pre-wetted in 2 × SSC. The membranes were 
prehybridized in 35 ml of a solution containing 50% formamide, 5 × SSC, 1% casein (Sigma, St 
Louis MO), 5 × Denhardt’s reagent50, 25 mM sodium phosphate (pH 6.5) and 0.5 mg ml−1 yeast 
RNA (Roche). Thirty five milliliters of this solution were placed into a plastic hybridization bag 
containing the membrane. The sealed bag was incubated at 70°C for at least 90 min. Each pre-
hybridized membrane with fixed TNA was placed in a Miniblotter 45 (Immunetics, Boston MA), 
with the “lanes” of TNA at 90 degrees to the channels of the device. A 30 × 45 ‘checkerboard’ 
pattern was produced. 
Probes were diluted in a proprietary hybridization buffer (UltraHyb Oligo buffer; Ambion, 
Austin, TX). The final concentration of the different probes in each lane in the Miniblotter 45 
varied from 2 to 60 pM. The digoxigenin-labeled LNA-oligonucleotide probes, diluted in 
UltraHyb Oligo buffer, were placed in individual lanes of the Miniblotter. Empty lanes were filled 
with hybridization solution. The entire apparatus was wrapped in Saran® Wrap and placed in a 
sealed Ziploc® bag containing 50mL of water to prevent evaporation43. Membranes were 
hybridized at 70°C for 90 min, followed by a high stringency washing (250 mL sterile 2 × SSC, 
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0.5% SDS at 63°C) in a shaking water bath for 1 hour, replacing the buffer after 30 minutes.  
Membranes were blocked in a maleic acid buffer (0.1 M maleic acid, 3 M sodium chloride, 0.3 % 
Tween™ 20, pH 8.0) containing 1% casein on a rotator at room temperature for at least 1 hour. 
The membranes were then incubated with a 1:6250 dilution of anti-digoxigenin antibody 
conjugated with alkaline phosphatase (Roche, Indianapolis, IN, Sigma-Aldrich) on a rotator for 30 
min. The membranes were rinsed with maleic acid buffer for 1 min to remove excess antibody and 
then washed three times with that buffer for 15 min each time. The membranes were equilibrated 
in 100 ml ‘buffer 3’ (0.04% magnesium chloride and 2.1% diethanolamine pH 9.5) for 5 min. 
Finally, 1 ml of a chemiluminescent substrate (CDP Star; Tropix, Bedford, MA) was diluted in 4 
ml of ‘buffer 3’. The final solution was deposited onto the membrane surface and the membrane 
was placed in a reaction folder (GE Healthcare-Whatman) The membranes were exposed and the 
light photons are captured with a GE ImageQuant LAS 4000 for 10 minutes. 
Preparation of the Standards for Quantification 
The standards for detection using LNA-oligonucleotide probes were a mixture of sequences 
complementary to the oligonucleotide probes designed to detect both the cultivable and as yet 
uncultivated taxa. The ‘complementary’ sequences (Table 2) were synthesized by Sigma 
(Woodlands, TX). Each membrane contained six standards, each containing 0.004, 0.04, 0.4 or 4 
pM of each sequence concentrations for quantification of each test species as well as two standards 
containing the ‘complementary’ of the eubacterial probe (4 pm and 40 pm).   Ninety microliters 
2% glutaraldehyde and 910 µl 6 × SSC were added to the standards and the final solutions of the 
standards were deposited as the last six lanes of each membrane. 
The standard concentrations were based on the estimation that 0.004, 0.04, and 0.4 pM of the 
complementary probe sequence would approximate 105, 106, and 107 bacterial cells. As bacterial 
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cells were not available from uncultivated taxa, cultivated bacterial species were employed to test 
this estimate. Signals were compared from samples containing 10 ng TNA, 106 bacterial cells and 
0.04 pM oligonucleotide sequences. These targets were hybridized with probes to the species and 
the intensities of the signals were compared4. One quality control sample was also included in each 
membrane. The QC sample was comprised of TNA extracted by MagMAX™ Pathogen 
RNA/DNA Kit on the Kingfisher Flex from 192 subgingival plaque samples collected from 
subjects with mild to severe periodontitis.  The extracted TNA was pooled, aliquoted into 
microcentrifuge tubes and frozen at – 80 0 C until use. 
Determination of Probe Sensitivity and Specificity 
Bacterial suspensions were prepared from pure cultures. Upon harvesting, the cell density of 
each species was adjusted to an optical density at 600 nm of 1 and 108 cells of each species were 
pipetted into a microcentrifuge tube. The resulting suspension was serially 10-fold diluted and 
TNA from each dilution was individually extracted using the Masterpure RNA purification kit 
(Epicentre, Madison, WI). The samples were quantified as described above. 
In order to assess the sensitivity of detection of the oligonucleotides, three different probes 
were compared: conventional oligonucleotides RNA probes, conventional oligonucleotides DNA 
probes and LNA-oligonucleotides probes. The probes were ran in the membrane against the total 
nucleic acids extracted from selected cultivable bacterial species used as targets in different 
concentrations (105 and 106). The bacteria selected for this experiment were: T. forsythia, P 
intermedia, F. nucleatum, P. gingivalis, P. endodontalis, S. anginosus/gordonii, A. geminatus, P. 
micra (Fig 1). 
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To determine the specificity of the probes and the best concentrations of probes to use for all 
signals to "calibrate" the probe concentrations, two different experiments were performed: 
Positive cross-reaction:10 ng TNA from 22 selected bacterial species for the study, as well as 
22 LNA-oligonucleotides probes, were laid on the nylon membranes using a Minislot. The 
membranes were then ‘probed’ in a checkerboard format using all the oligonucleotide probes (Fig 
4). 
Negative cross-reaction: 10 ng TNA from 96 different bacterial species commonly found in 
the oral cavity, 22 LNA-oligonucleotides probes, were laid on the nylon membranes using a 
Minislot. The membranes were then ‘probed’ in a checkerboard format using all the 
oligonucleotide probes (Fig 5). 
Determination of the bead-based kit to extract TNA 
In order to optimize the TNA extraction, we tested the automated extraction by using the 
KingFisher technology (Thermo Fisher Scientific, Waltham, MA). Kingfisher Flex instrument 
uses magnetic bead technology to automate TNA purification reducing variability and hands-on 
time utilizing magnetic rods, so we needed to change the extraction kit from Masterpure (scalable 
salt-precipitation protocol) to a magnetic bead-based extraction kit. 
To test what is the best bead-based kit to extract TNA for further use in the automated 
extraction, 2 kits with different protocols were used and compared with the manual Masterpure 
protocol. Kit 1: MagMAX™ Pathogen RNA/DNA Kit after cell disruption using the lysing buffer 
provided by the kit, Kit 2: MagMAX™ Pathogen RNA/DNA Kit after cell disruption using the 
lysing buffer provided by the kit and using the RNAse step, Kit 3: MagMAX™ Pathogen 
RNA/DNA Kit after cell disruption using the glass beads protocol (below), Kit 4: Mag-Bind® 
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Universal Pathogen DNA Kit after cell disruption using the lysing buffer provided by the kit, Kit 
5:  Mag-Bind® Universal Pathogen DNA Kit after cell disruption using the lysing buffer provided 
by the kit and using the RNAse step, Kit 6:  Mag-Bind® Universal Pathogen DNA Kit after cell 
disruption using the glass beads protocol (Fig 5). All methods followed the manufactures’ protocol. 
For the Glass beads lysis, the samples were centrifuge cells at max speed for 10 minutes. The 
supernatants were discarded and the samples were resuspended in 1ml dilution of lysis buffer 
(50mM NaH2PO4, 300mM NaCl, 10mM imidazole, pH 8.0) in a 1.5mL tube. Approximately 
0.5mL of Glass beads (diameter 500 µm, Thermo Fisher Scientific, Waltham, MA) was added and 
left on ice for 5 min. The sample were disrupted in a Mini-BeadBeater (Sigma-Aldrich, St. Louis, 
MO) for 5 min and then centrifuge at 14,000rpm for 20 minutes. The supernatants were transferred 
to a new tube and the glass beads were discarded. 
Pilot Clinical Study  
To assess the feasibility of the proposed method, a small pilot study was conducted. Five 
periodontally healthy individuals and 16 patients with periodontitis were selected for study.  
The subjects were recruited for the Biomarkers of Periodontal Disease Progression NIH, 
NIDCR: 5U01DE021127).  
Ethical standards: The investigators ensure that this study was conducted in full conformity 
with the principles set forth in The Belmont Report:  Ethical Principles and Guidelines for the 
Protection of Human Subjects of Research, as drafted by the US National Commission for the 
Protection of Human Subjects of Biomedical and Behavioral Research (April 18, 1979) and 
codified in Title 45 of the CFR Part 46 and/or the ICH Guideline for Good Clinical Practice (ICH 
E6; 62 Federal Register 25691, 1997). The investigators also ensure that the study was conducted 
	
23	
according to the principles of Good Clinical Practice and the Declaration of Helsinki. All aspects 
of this study was in accordance with all national, state, and local laws of the pertinent regulatory 
authorities. 
Subjects: After signing the consent form, the subject underwent evaluation of eligibility 
criteria (including periodontal measurements), a medical and dental history, assessment of 
concomitant medications, urine pregnancy test (in women with childbearing potential), complete 
oral examination, and full mouth radiographs series (radiographs will not be performed if the 
subject does not meet all preceding eligibility criteria).  
Within 6 weeks after the screening visit, subjects will return for the baseline visit, which marks 
the beginning of the disease progression and monitoring phase. At this visit, they underwent an 
interim medical and dental history; complete oral examination; urine pregnancy test (in women 
with childbearing potential); measurements of height and weight; assessment of concomitant 
medications; evaluation for unanticipated problems; collection of baseline biological samples; and 
baseline periodontal measurements. 
The periodontal assessments were performed on 6 sites per tooth for all teeth (excluding third 
molars) and included the presence or absence of gingival redness; presence or absence of plaque, 
probing depth (PD); measurement of distance from the cemento-enamel junction (CEJ) to the free 
gingival margin (B measure); clinical attachment level (calculated by subtracting the B measure 




Measurement calibration: Calibration exercises was performed at the Forsyth Institute prior 
to the start of the study to evaluate intra- and inter-examiner variability. The gold standard was a 
Dental Hygienist from the School of Dentistry, University of North Carolina at Chapel Hill. 
PD and B measure were measured twice, CAL was calculated for each pass, and the median 
of the measurements was used for analysis. If the difference between the 2 measurements was 
greater than or equal to 2 mm, the examiner was prompted to measure PD and B measure a third 
time. When 3 measurements were obtained, the median CAL measurement was used for analysis.  
When recession is present, B measure was recorded as a negative number, and when the gingival 
margin is coronal to the CEJ, B measure was recorded as a positive number.  Clinical attachment 
level was calculated by subtracting the B measure from the PD. 
Inclusion criteria: To be eligible to participate in this study, a subject must meet all of the 
following criteria: 
Ability to understand, willingness and ability to read and sign the informed consent form. Age 
of at least 25 years. Ability to understand and follow directions for study procedures. Willingness 
to comply with all study procedures and be available for the duration of the study. For women with 
reproductive potential, willingness to use highly effective contraception (e.g., licensed hormonal 
contraception, intrauterine device, abstinence, or vasectomy in partner). Minimum of 20 natural 
teeth, excluding third molar teeth; at least 12 of these teeth must be pre-molars, first molars, or 
second molar. 
To ensure a balanced distribution of subjects throughout the spectrum of clinical 
manifestations, subjects with periodontal disease were stratified according to disease extent and 
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severity. Thus, there will be 2 sets of inclusion criteria:  subjects with mild periodontal loss and 
subjects with severe periodontal loss.  
Subjects with mild periodontal loss must meet all of the following criteria and must not meet 
the minimum criteria for severe periodontal loss: 
At least 4 teeth with at least 1 site of PD of 5 mm or more and concomitant CAL greater than 
or equal to 2 mm, and radiographic evidence of mesial or distal alveolar bone loss around at least 
2 of the affected teeth. Alveolar bone loss is defined as a distance of greater than 2 mm measured 
radiographically from the CEJ to the crest of the alveolar bone 
Subjects with severe periodontal loss must meet all the following criteria:  
At least 8 separate teeth with at least 1 site of PD of 5 mm or more and concomitant CAL 
greater than or equal to 3 mm, and radiographic evidence of mesial or distal alveolar bone loss 
around at least 2 of the affected teeth. Alveolar bone loss is defined as a distance of greater than 2 
mm measured radiographically from the CEJ to the crest of the alveolar bone. 
A periodontally healthy subject must meet all of the following criteria:  
Any tooth with 3 mm or less PD, irrespective of the attachment level, was acceptable. No teeth 
with PD of 4 mm or more and concomitant attachment loss, with the exception of the distal of the 
second molars where a PD of 4 mm and concomitant CAL of up to 2 mm were acceptable. No 
radiographic evidence of f alveolar bone loss (defined as a distance of greater than 2 mm measured 
radiographically from the CEJ to the crest of the alveolar bone); with the exception of the 
mandibular incisors where up to 3 mm of alveolar bone loss measured radiographically from the 
CEJ to the crest of the alveolar bone will be accepted. 
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Exclusion criteria: A potential subject will be excluded from participation in this study if 
he/she meets any of the following criteria: 
Presence of orthodontic appliances. Acute necrotizing ulcerative gingivitis or gross tooth 
decay as determined by the investigator. Root fragments, pericoronitis, endo-perio lesions, or other 
dental abscesses. Subjects were rescreened after resolution of these dental conditions. Pregnancy 
or lactation. If a subject meets this criterion, she was rescreened for study participation when she 
no longer meets the criterion. Requirement for prophylactic antibiotics for dental procedures (e.g., 
for certain heart and orthopedic conditions). Periodontal or systemic antibiotic therapy in the 
previous 6 months. If a subject meets this criterion, he/she was rescreened for study participation 
when he/she no longer met the criterion. Use of cigarettes or other tobacco products within 1 year 
before the screening visit. If a subject meets this criterion, he/she was rescreened for study 
participation when he/she no longer met the criterion. Any medical condition that might influence 
the course of periodontal disease or treatment (e.g., diabetes [irrespective of level of control], 
human immunodeficiency virus infection or acquired immunodeficiency syndrome, use of 
medications associated with gingival hyperplasia), chronic use of non-steroidal anti-inflammatory 
drugs (e.g., for arthritis), defined as the need, or anticipated need, for over 3 weeks of continuous 
use at the time of enrollment or during the course of the study.  The use of low-dose aspirin (≤ 81 
mg/day) for prophylaxis was allowed. Current or anticipated use of chronic systemic 
corticosteroids, cyclosporine, or another systemic immunosuppressive agent.  The use of inhaled 
corticosteroids was allowed. Hypersensitivity to tetracyclines (e.g., tetracycline, doxycycline, 
minocycline). Participation in a clinical study testing a drug, biologic, device, or other intervention 
within the last 30 days. If a subject meets this criterion, he/she was rescreened when he/she no 
longer met the criterion. Any condition or circumstance that, in the opinion of the investigator, 
	
27	
would place the subject at increased risk or preclude his/her full compliance with or completion of 
the study 
The patient will be excluded if the following conditions are noted on oral examination: Oral 
lichen planus, candidiasis, clinical leukoplakia, clinical erythroplakia, pemphigus, pemphigoid, 
other recurrent intraoral or perioral vesiculobullous diseases, aphthous ulcerations (major or 
minor). Subjects presenting with aphthous ulcers were rescreened after 2 weeks. They were 
eligible if the ulcers have healed and the subject does not have a history of frequent recurrences. 
Subjects presenting with herpes labialis or intraoral herpes were rescreened after 2 weeks. They 
were eligible if the lesions have healed and the subject does not have a history of frequent 
recurrences. If a subject present with a traumatic ulcer, he/she was rescreened in 2-3 weeks.  The 
subject was eligible if the ulcers have healed. 
Collection of samples: Subgingival plaque samples were collected at the baseline visit. They 
were taken using 11/12 sterile Gracey curettes and placed in individual microcentrifuge tubes 
containing 100 ul RNAse-free TE buffer. Each sample was placed in an individual microcentrifuge 
tube containing storage buffer and stored at 80º C. Specimen Shipment Samples were stored at the 
original center of collection. Pre-barcoded vials were used to identify all collected samples, and 
barcode scanners and software were used to catalogue and track them. Stored samples were 





This statistic below will be used to analyze the data from the 4,000 biofilm samples in the 
“Biomarkers of Periodontal Disease Study” after the RQT technique optimization presented in this 
thesis. 
The images obtained were analyzed using Phoretix Array Software (TotalLab, Newcastle, 
UK) and the signal intensities of the samples and the standards were measured. Signals were 
converted to approximate ‘counts’ by comparison with the standards on each membrane. The 
‘counts’ were computed by estimating that 0.04 pM of target sequences in the standard was 
equivalent to approximately 106 cells and that 0.004 pM target sequences approximated 105 cells. 
Absence of signal detection was recorded as zero. In clinical samples, ‘counts’ for each taxon were 
averaged within a subject and then across subjects in the periodontitis and periodontally healthy 
groups, separately. Significance of differences between subject groups was determined using the 










The first step was to assess what type of probe provides more sensitivity, specificity and 
throughput for the ROQT method. In order to answer these questions, we tested DNA, RNA, and 
LNA-oligonucleotides probes against their RNA, DNA, TNA, and their poly-T sequences 
sequences. 
We observed that LNA-oligonucleotides probes provide higher sensitivity of detection of the 
oligonucleotides probes when is compared with conventional oligonucleotides RNA and DNA 
probes (Fig 1). In addition, there was no difference observed between the RNA and DNA signal 
and their poly-T sequences (Fig 2). Finally, the sample’s reverse RNA provides the strongest signal 
when compared to the reverse DNA (Fig 3). It is also important to point out that the reverse DNA 
also provides some weak signal, therefore the decision was to use the total nucleic acid to get both, 
RNA and DNA, signals.  
After the selection of the LNA-oligonucleotides probe, we needed to "calibrate" the probe 
concentrations in order to optimize the probe and to have a standardize positive control for each 
oligo sequences from the selected bacteria. After several experiments and concentration 
adjustments, we found the best concentration of each probe. It can be observed in the figure 4 that 
each probe reacted against its standard. 
Also, in order to assess the specificity of the probes, it was important to know if there was a 
cross-reaction with the selected probe and other bacterial species commonly found in the oral 
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cavity. For this experiment, we ran the selected 22 LNA-oligonucleotides probes against 10 ng 
TNA from 96 different bacteria (Fig 5A). We observed that P. endodontalis ot273 was the most 
cross-reacted probe with other bacterial sequences (Fig 5B). Therefore, we decided to exclude this 
probe from the final membrane. 
When different kits and protocols were compared, the best results in terms of sensitivity was 
observed with the use of the MagMAX™ Pathogen RNA/DNA Kit after cell disruption using the 
lysing buffer provided by the kit without the RNAse step (Fig 6). 
For the final selection of the extraction method, samples from 16 patients with moderate 
periodontitis were used. 4x4 samples were pulled together and subsequently divide by 4 samples. 
The TNA were extracted using the manual Masterpure protocol (MP) or the automated protocol 
using the previously selected kit (MagMAX™ Pathogen RNA/DNA Kit) performed at different 
stringency conditions (63C and 70C). We observed that the automated method at 63C consistently 
yields stronger signals in comparison to the manual protocol (Fig 7).  
In order to quantify the concentration of bacteria presented in each sample, positive control 
with 3 different concentration, each containing 0.004, 0.04, 0.4 pM, as well as two standards 
containing the ‘complementary’ of the eubacterial probe (0.4 and 4 pm) were added in each 
membrane. It can be observed in the figure 8 that all the standards could be presented in the curve 
that could “fit” all samples (not shown). 
To assess the reproducibility of the membranes, we decided to add one QC (quality control 
sample) in each membrane. In order to standardize the sample, 200 biofilm samples from drop-off 
patients were pulled together and subsequently divided into 200 aliquots. The TNA were extracted 
and used one sample in each membrane. Figure 9 shows 12 of these samples, we can observe that 
	
31	
they are reproducible. In addition, we have tested different concentration of the elution buffer and 
glutaraldehyde and we decided to keep the original protocol: 90ul of the elution buffer after the 
use of 2% glutaraldehyde for the sample preparation. 
Finally, we selected biofilm samples from healthy, moderate and severe patients and ran a 
pilot study to see if different bacteria concentrations could be observed. Figure 10 shows that the 
most commonly detected uncultivated/unrecognized species in the samples from severe sites were 
probe Treponema sp ot254, TM7 ot356, Fretibacterium sp ot360, Y73 Selenomonas sp ot134, 54, 
L66 and Desulfobulbus sp. ot041. In the cultivated segment of the microbiota, the most abundant 
taxa were Tannerella forsythia OT 613, Oribacterium sp ot78, K76 Bacterioidetes sp ot274, 
Fretibacterium fastidiosum OT 363 and Porphyromonas gingivalis ot619.  
After improving the sensitivity, specificity of the method we were ready to run all the 4000 
samples from the “Biomarkers of Periodontal Disease Progression” study (NIH, NIDCR: 










Periodontal diseases are polymicrobial infections that can lead to periodontal inflammation 
and alveolar bone and tooth loss. Periodontal diseases are multifactorial diseases, whose initiation 
and progression require the participation of several factors, particularly the involvement of 
subgingival bacteria that contribute to the polymicrobial biofilm formation51.  
Much of our current knowledge of the microbial etiology of periodontitis derives from 
detailed cultural characterization of the periodontal microbiota52–56. Socransky et al., 19982 using 
whole genomic DNA probes and checkerboard DNA–DNA hybridization, characterized 
periodontal microbial communities classified in distinct complexes that reflected cluster analysis, 
community ordination and associated disease severity. They identify the ‘red complex’, a group 
of three species including Porphyromonas gingivalis, Treponema denticola and Tannerella 
forsythia, that which was strongly associated with each other and with diseased sites. The oral 
cavity harbors a complex microbiome, with close to 700 predominant taxa1. In the past decade, it 
has become clear that a substantial portion of the oral microbiome was not fully characterized 
(15%) or could not be cultivated (35%)1. Most of the information regarding the association of 
unrecognized uncultivable/taxa with periodontal health and disease is based on techniques that 
provide presence/absence data46,57. Also, most of those techniques involve sample dilution, sample 
pooling or PCR amplification of which can add bias to the microbial results6,8,10,49,58. The use of 
next generation sequencing has expanded the breadth of knowledge of the oral microbiota, but 
only small numbers of subjects and samples have been reported59,60. Even though those taxa have 
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remained undetected in most studies, it is possible that specific uncultivated/unrecognized taxa 
may play a role in the etiology of oral diseases, or alternatively, they may represent beneficial 
bacterial species 
Quantification is important in the study of periodontal diseases because the differences 
between periodontal health and disease and before and after therapy are quantitative, rather than 
qualitative2,11. For this reason, quantification of individuals biofilms is necessary. Species 
quantification in samples from periodontal sites with different clinical status in the same or 
different oral cavities is a powerful first step in discriminating pathogens from host-compatible 
species. Our mthod gives us the ability to quantify the number of the bacterial taxa presented in 
each sample. For this, we need to calculate the concentration of the sample in relation with the 
known concentration used as a standard (Fig. 8).   
Because periodontal diseases are site-specific, can occur in any of the 168 typically 
evaluated clinical sites and often develops in only a small subset of those sites, there was a need 
to improve the throughput of microbial techniques, to accommodate the analysis of a larger number 
of samples per individual61. 
The aim of the present study was to improve a method to detect and quantify uncultivated 
bacterial species in subgingival biofilm samples in periodontal health and disease. The specificity 
of the probes used was confirmed by the absence of cross-reactions with any of the 96 bacterial 
taxa tested, representing the most prominent cultivable oral bacterial taxa. The small clinical study 
demonstrated the feasibility of the method for its use in clinical trials. The strengths of the proposed 
method include the absence of pooling, amplification or dilution bias, because an entire individual 
sample is laid onto the membrane. It allows the quantification of both cultivable and uncultivable 
bacterial taxa. It is high throughput, in that multiple samples can be analyzed for the levels of 
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multiple species at the same time on a single membrane and it is relatively inexpensive. The 
method also has limitations. The standard curve presented has three data points, which enables 
quantification of taxa in the 104 to 107 cells range in a given sample. However, additional levels of 
standards can be added to provide a tighter or more comprehensive standard curve. The data 
presented above were obtained using an image capture by a CCD camera, reaching a dynamic 
range of 4.8 orders of magnitude and enhancing the accuracy of the method. Although the format 
of the ROQT may resemble that of the checkerboard DNA–DNA hybridization technique43,62, it is 
not meant to represent a ‘more sensitive checkerboard’. The techniques differ in the nature of the 
probes, their target molecules, their hybridization protocols and the nature of the species. The use 
of ROQT can overcome some of the limitations presented by other molecular biology techniques, 
including checkerboard DNA-DNA hybridization, real time PCR and 16S rRNA cloning analysis. 
None of these techniques can quantify the levels of multiple uncultivated species in large numbers 
of individual biofilm samples simultaneously. 
In the present study, the standards for quantification of individual taxa contained 0.004, 
0.04 and 0.4 pM of the sequences complementary to the probes. These levels were estimated based 
on the molecular weight of the 16S rRNA molecule and the number of copies thought to be present 
in bacterial cells. Subsequent experiments indicated that 0.04 pM yielded signals equivalent to 
about 0.44 × 105 bacterial cells. In this study, we compare biofilm samples from patients with 
moderate periodontitis extracted using the manual Masterpure protocol (MP) and the automated 
protocol (MagMAX™ Pathogen RNA/DNA Kit with Kingfisher Flex instrument) performed at 
different stringency conditions (63C and 70C). It can be observed that the automated method 
consistently yields stronger signals in comparison to the MP protocol (Figure 7). The possibility 
of use an automated TNA extraction allows an optimization of entire process.  
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ROQT hybridization technique offers a number of advantages. The principal advantage is that 
large numbers of DNA, RNA, tissue, bacterial or viral samples could be tested with multiple probes 
at the same time62. ROQT represents a hybrid of checkboard and HOMIM: combines the ability 
to assess levels of taxa, without an amplification step (aliquot and PCR can introduce bias, the 
entire sample is used); have the ability to detect uncultivated/unrecognized taxa thanks to the 
specificity of the oligonucleotide probe that are the same ones used in HOMIM46,57. One major 
difference and an advantage in relation to both techniques is that it targets RNA, rather than DNA. 
DNA based techniques do not differentiate live/dead cells, since DNA can be present even after 
cell death. In contrast, because rRNA is essential to basic cellular metabolism and it is thought to 
degrade soon after cell death, RNA targeting techniques provide better representation taxa actively 
involved in health and disease. ROQT can quantify the levels of multiple uncultivated species in 
large numbers of individual biofilm samples simultaneously and is a high-throughput method for 
bacterial enumeration in clinical biofilm samples and have been used in several studies12,13,47,51. 
The short length and high sequence similarity between closely related microRNAs makes it 
hard to detect them with sufficient specificity and sensitivity. Locked nucleic acid (LNA) is one 
type of nucleotide analogues having a methylene bridge between O2′ and C4′ atoms of ribose to 
form a bicyclic ribosyl structure. It is the bridged structure that ‘locks’ effectively the ribose in the 
C3′-endo sugar pucker conformation, which is observed primarily in A-form DNA and RNA63. 
LNA modified probes can enhance the binding affinity towards their complementary DNA strands 
due to the improved base stacking and phosphate backbone preorganization64, and can improve 
their capability of discriminating the mismatched base pairs65. For this reason, the use of LNA-
oligonucleotides probes is superior to DNA technologies, because only the perfect match with the 
complementary RNA will occur. For comparison, we tested DNA oligonucleotides probes, RNA 
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oligonucleotides probes and LNA oligonucleotides probes (Figure 1-3). Results showed that DNA 
and RNA probes exhibited lower signal intensity than LNA-modified probes under the same  
In the cultivated segment of the microbiota, we observed that the most abundant taxa were 
Tannerella forsythia ot613, Fretibacterium fastidiosum ot363, L66 Oribacterium sp ot78, K76 
Bacterioidetes sp ot274, and Porphyromonas gingivalis ot619. Several studies showed that these 
bacteria were significantly more abundant in the periodontal patients with more inflammation2,77. 
For example, Oliveira et al. (2016)13 observed that subgingival biofilm from patients either with 
Aggressive and Chronic Periodontitis harbors higher amounts of the cultivated bacteria F. 
fastidiosum ot363, T. forsythia ot613 and P. gingivalis ot619, and the uncultivated Fretibacterium 
sp ot360, Y73 Selenomonas sp ot134, and TM7 ot356 when compared to the healthy sites. In 
addition, recent studies using 454 pyrosequencing to characterize healthy and periodontitis 
microbial communities48,78, the overall picture of bacterial associations with health and disease 
agree with the initial descriptions of the different oral microbial complexes described by Socransky 
et al. (1998)2. 
Due to the complexity of the oral community the initial causes for transition from a healthy 
microbial community to a dysbiotic one is still not known. It is important identify the presence and 
the levels of taxa involved in the dysbiotic environment that precedes the disease initiation. ROQT 
can examine large numbers of biofilm samples from large numbers of subjects helping in identify 
the more relevant uncultivated and unrecognized taxa. Identify these taxa is very important to 
further cultivation and identification of pathogenic mechanism involved in the establishment and 









The use of automated TNA extraction, LNA probes and RNA standards enhances the 








Table 1. List of the bacteria selected for this study, their presence in the NT list and the evidence 
of their role in periodontal disease. NT: New Technologies. The evidence number is the of times 















Figure 1. Comparison between conventional oligonucleotides RNA probes, conventional 
oligonucleotides DNA probes and LNA-oligonucleotides probes. Total nucleic acids extracted 
from selected cultivable bacterial species were used as targets in the horizontal lanes, cell targets 
were used in concentrations 105 and 106 respectively. The left-most lane is a universal probe to 













Figure 3. RNA oligonucleotide quantification technique (ROQT) membrane used to assess the 
different oligonucleotides DNA, RNA and LNA probes. Reverse DNA and RNA 0.04pmol from 
selected bacterial species were used as targets in the horizontal lanes. Oligonucleotides DNA, RNA 






Figure 4. The specificity of the probes was tested using 10ng of RNA oligo sequences from each 
of the selected bacteria.  Because of the unavailability of cells from uncultivated taxa, probes from 
those species were tested against their complementary oligonucleotide sequences. This membrane 
was used to determine the best concentrations of probes to use for all signals to be the same 





Figure 5. The specificity of the probes was tested using 10 ng of TNA from bacteria not selected 
for the study to see their cross-reaction. Panel A: List of the bacteria selected to analyze if there is 
a cross-reaction between these bacteria the ones selected for the study. Panel B: membrane 






Figure 6. RNA oligonucleotide quantification technique (ROQT) membrane after TNA extraction 
using different magnetic based kit compared against the standard kit Materpure. Kit 1:  
MagMAX™ Pathogen RNA/DNA Kit after cell disruption the lysing buffer provided by the kit, 
Kit 2: MagMAX™ Pathogen RNA/DNA Kit after cell disruption the lysing buffer provided by the 
kit and using the RNAse step, Kit 3: MagMAX™ Pathogen RNA/DNA Kit after cell disruption 
with glass beads, Kit 4: Mag-Bind® Universal Pathogen DNA Kit after cell disruption the lysing 
buffer provided by the kit, Kit 5:  Mag-Bind® Universal Pathogen DNA Kit after cell disruption 
the lysing buffer provided by the kit and using the RNAse step, Kit 6:  Mag-Bind® Universal 






Figure 7. Figure shows samples extracted using the manual Masterpure protocol (MP) and the 
automated protocol (MagMAX™ Pathogen RNA/DNA Kit with Kingfisher Flex instrument) 
performed at different stringency conditions (63◦C and 70◦C). Samples represent 4 patients with 
severe periodontal disease. The sample of each patient was divided in two and the TNA extracted 
with MP and MagMAX™ Pathogen RNA/DNA Kit and were hybridized with 23 probes 






Figure 8. Panel A: RNA oligonucleotide quantification technique (ROQT) membrane showing the 
standards and the universal probe. Each membrane contained three standards, each containing 
0.004, 0.04, 0.4 pM of each sequence concentrations for quantification of each test species as well 
as two standards containing the ‘complementary’ of the eubacterial probe (0.4 and 4 pm). Panel 






Figure 9. Figure shows different concentration of the elution buffer and glutaraldehyde. 200 TNA 









Figure 10. A checkerboard membrane showing hybridization of clinical samples with 
LNA_oligonucleotide probes. Probes for cultivated species and as yet uncultivated species are 
listed across the bottom. Each horizontal lane represents the total nucleic acids (TNA) from a 
sample from Health, Moderate, and Severe periodontal disease sites. Each membrane contained 
standards (0.004, 0.04, 0.4 pM) and the standards containing the ‘complementary’ of the 






Figure 11. A final checkerboard membrane showing hybridization of clinical samples with 
LNA_oligonucleotide probes. Probes for cultivated species and as yet uncultivated species are 
listed across the bottom. Each horizontal lane represents the total nucleic acids (TNA) from biofilm 
sample. Standards comprised a mixture of ‘complementary’ sequences from all the test taxa at 0.4, 
0.04 and 0.004 pM, and the Universal probes respectively.  (U standards are 0.04 with the S0.004 
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